s6y

Anbio Biotechnology

Ticker
NNNN
CIK
1982708
Industry
In Vitro & In Vivo Diagnostic Substances

Ownership 7

  1. 3 Initial statement of beneficial ownership of securities
  2. 3 Initial statement of beneficial ownership of securities
  3. 3 Initial statement of beneficial ownership of securities
  4. 3 Initial statement of beneficial ownership of securities
  5. 3 Initial statement of beneficial ownership of securities
  6. 3 Initial statement of beneficial ownership of securities
  7. 3 Initial statement of beneficial ownership of securities

Prospectus 12

  1. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  2. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  3. DRSLTR Correspondence Related to Draft Registration Statement
  4. DRS/A Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  5. DRS/A Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  6. DRSLTR Correspondence Related to Draft Registration Statement
  7. DRS/A Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  8. DRS/A Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  9. DRSLTR Correspondence Related to Draft Registration Statement
  10. DRS/A Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

All 12 prospectus filings

Other 24

  1. F-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers
  2. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  3. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  4. 20-F/A Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
  5. 20-F Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
  6. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  7. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  8. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  9. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  10. 20-F Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

All 24 other filings